Editorial: (New Drug (LCZ696) for the Treatment of Heart Failure with Reduced Ejection Fraction After 10 Years. Can One Study Change the Guidelines?)

Publisher： Bentham Science Publishers

E-ISSN： 1875-6212|12|6|867-869

ISSN： 1570-1611

Source： Current Vascular Pharmacology, Vol.12, Iss.6, 2014-11, pp. : 867-869

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment of Hypertension in Heart Failure with Preserved Ejection Fraction

By  

Current Hypertension Reviews, Vol. 10, Iss. 3, 2014-09 ,pp. : 142-148

Bentham Science Publishers

Access to resources Recommend Favorite

A Practical Guide for the Treatment of Symptomatic Heart Failure with Reduced Ejection Fraction (HFrEF)

By  

Current Cardiology Reviews, Vol. 11, Iss. 1, 2015-02 ,pp. : 23-32

Bentham Science Publishers

Access to resources Recommend Favorite

A Practical Guide for the Treatment of Symptomatic Heart Failure with Reduced Ejection Fraction (HFrEF)

By  

Current Cardiology Reviews, Vol. 11, Iss. 1, 2014-11 ,pp. : 23-32

Bentham Science Publishers

Access to resources Recommend Favorite

Treating Heart Failure with Preserved Ejection Fraction Related to Arterial Stiffness. Can we Kill Two Birds With One Stone?

By  

Current Vascular Pharmacology, Vol. 13, Iss. 3, 2015-05 ,pp. : 368-380

Bentham Science Publishers

Access to resources Recommend Favorite

Diagnosis and Management of Heart Failure with Preserved Ejection Fraction: 10 Key Lessons

By  

Current Cardiology Reviews, Vol. 11, Iss. 1, 2015-02 ,pp. : 42-52

Bentham Science Publishers

Access to resources Recommend Favorite